Random Trial for Elderly Patients With NSCLC
NCT00265694
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG:
vinorelbine, gemcitabine and carboplatin
Sponsor
Inje University